The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations
Abstract
Fluctuations in the symptoms of Parkinson's disease (PD), such as wearing-off and on-off effects, and dyskinesias are related to a variety of factors, including duration and dosage of levodopa, age at onset, stress, sleep, food intake, and other pharmacokinetic and pharmacodynamic mechanisms. The majority of patients, particularly those with young onset of PD, experience these levodopa-related adverse effects after a few years of treatment. Assessment of these motor complications is difficult because of the marked clinical variability between and within patients. Daily diaries have been used in clinical trials designed to assess the effects of various pharmacological and surgical interventions on motor fluctuations and dyskinesias. The most common type of dyskinesia, called "peak-dose dyskinesia", usually consists of stereotypical choreic or ballistic movements involving the head, trunk, and limbs, and occasionally, the respiratory muscles, whereas tremor and punding are less-common complications. Dystonia is also typically seen in patients with diphasic dyskinesia and wearing-off effect. Recognition of the full spectrum of clinical phenomenology of levodopa-related motor complications is essential for their treatment and prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
Ahlskog, J. E., & Muenter, M. D. (2001) · Movement Disorders · doi:10.1002/mds.1090 · Cited by 1,454
A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
Olanow, C. W., Goetz, C. G., Kordower, J. H., Stoessl, A. J., Sossi, V., Brin, M. F., Shannon, K. M., Nauert, G. M., Perl, D. P., Godbold, J., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10720 · Cited by 1,307
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,037
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
Dyskinesias and motor fluctuations in Parkinson's disease
Schrag, A., & Quinn, N. (2000) · Brain · doi:10.1093/brain/123.11.2297 · Cited by 600
Giovannoni, G. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.4.423 · Cited by 587
Parkinson Study Group (1996) · Annals of Neurology · doi:10.1002/ana.410390107 · Cited by 356
Parkin disease: a phenotypic study of a large case series
Khan, N. L., Graham, E., Critchley, P., Schrag, A. E., Wood, N. W., Lees, A. J., Bhatia, K. P., & Quinn, N. (2003) · Brain · doi:10.1093/brain/awg142 · Cited by 352
Schrag, A. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.67 · Cited by 327
Health related quality of life in Parkinson's disease: a prospective longitudinal study
Karlsen, K. H. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.5.584 · Cited by 326
Hauser, R. A., Friedlander, J., Zesiewicz, T. A., Adler, C. H., Seeberger, L. C., O'Brien, C. F., Molho, E. S., & Factor, S. A. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200003000-00003 · Cited by 300
Young‐ versus older‐onset Parkinson's disease: Impact of disease and psychosocial consequences
Schrag, A., Hovris, A., Morley, D., Quinn, N., & Jahanshahi, M. (2003) · Movement Disorders · doi:10.1002/mds.10527 · Cited by 287
Treatment interventions for Parkinson's disease: an evidence based assessment
Rascol, O., Goetz, C., Koller, W., Poewe, W., & Sampaio, C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08520-3 · Cited by 279
Dopamine dysregulation syndrome in Parkinson's disease
Evans, A. H., & Lees, A. J. (2004) · Current Opinion in Neurology · doi:10.1097/01.wco.0000137528.23126.41 · Cited by 257
(2000) · Annals of Neurology · doi:10.1002/1531-8249(200001)47:1<2::aid-ana2>3.0.co;2-b · Cited by 249
Parkinson Disease, the Effect of Levodopa, and the ELLDOPA Trial
Fahn, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.529 · Cited by 245
Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
Marconi, R., Lefebvre‐Caparros, D., Bonnet, A., Vidailhet, M., Dubois, B., & Agid, Y. (1994) · Movement Disorders · doi:10.1002/mds.870090103 · Cited by 237
Comparison of Immediate-Release and Controlled Release Carbidopa/Levodopa in Parkinson’s Disease
Block, G., Liss, C., Reines, S., Irr, J., & Nibbelink, D. (1997) · European Neurology · doi:10.1159/000117399 · Cited by 234
Siderowf, A., McDermott, M., Kieburtz, K., Blindauer, K., Plumb, S., Shoulson, I., & the Parkinson Study Group (2002) · Movement Disorders · doi:10.1002/mds.10011 · Cited by 234
Dyskinesia after fetal cell transplantation for parkinsonism: A PET study
Ma, Y., Feigin, A., Dhawan, V., Fukuda, M., Shi, Q., Greene, P., Breeze, R., Fahn, S., Freed, C., & Eidelberg, D. (2002) · Annals of Neurology · doi:10.1002/ana.10359 · Cited by 219
Advantages of a modified scoring method for the rush video-based tic rating scale
Goetz, C. G., Pappert, E. J., Louis, E. D., Raman, R., & Leurgans, S. (1999) · Movement Disorders · doi:10.1002/1531-8257(199905)14:3<502::aid-mds1020>3.0.co;2-g · Cited by 215
Low‐dose L‐dopa therapy in Parkinson's disease: A 6‐year follow‐up study
Poewe, W. H., Lees, A. J., & Stern, G. M. (1986) · Neurology · doi:10.1212/wnl.36.11.1528 · Cited by 163
Dystonia in parkinson's disease: Clinical and pharmacological features
Poewe, W. H., Lees, A. J., & Stern, G. M. (1988) · Annals of Neurology · doi:10.1002/ana.410230112 · Cited by 162
Slowing Parkinson’s disease progression: Recent dopamine agonist trials
Ahlskog, J. E. (2003) · Neurology · doi:10.1212/01.wnl.0000044047.58984.2f · Cited by 161
Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms
Bravi, D., Mouradian, M. M., Roberts, J. W., Davis, T. L., Sohn, Y. H., & Chase, T. N. (1994) · Annals of Neurology · doi:10.1002/ana.410360108 · Cited by 160
Evaluation of 50 probands with early-onset Parkinson’s disease for Parkin mutations
Hedrich, K., Marder, K. S., Harris, J. M., Kann, M., Lynch, T., Meija‐Santana, H., Pramstaller, P. P., SCHWINGER, E., Bressman, S., Fahn, S., et al. (2002) · Neurology · doi:10.1212/wnl.58.8.1239 · Cited by 155
The spectrum of levodopa‐related fluctuations in Parkinson's disease
Riley, D. E., & Lang, A. E. (1993) · Neurology · doi:10.1212/wnl.43.8.1459 · Cited by 155
Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease
Pezzella, F. R., Colosimo, C., Vanacore, N., Rezze, S. D., Chianese, M., Fabbrini, G., & Meco, G. (2004) · Movement Disorders · doi:10.1002/mds.20288 · Cited by 154
Thomas, M., Hayflick, S. J., & Jankovic, J. J. (2004) · Movement Disorders · doi:10.1002/mds.10650 · Cited by 151
Self-citationTen-year follow-up of three different initial treatments in de-novo PD
Lees, A. J., Katzenschlager, R., Head, J. A., & Ben‐Shlomo, Y. (2001) · Neurology · doi:10.1212/wnl.57.9.1687 · Cited by 143
Jankovic, J., & Tintner, R. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00025-6 · Cited by 135
Self-citationLevodopa strengths and weaknesses
Jankovic, J. J. (2002) · Neurology · doi:10.1212/wnl.58.suppl_1.s19 · Cited by 131
Self-citationClinical–Pathological study of levodopa complications
Rajput, A. H., Fenton, M. E., Birdi, S., Macaulay, R. J. B., George, D. H., Rozdilsky, B., Ang, L. C., Senthilselvan, A., & Hornykiewicz, O. (2002) · Movement Disorders · doi:10.1002/mds.10031 · Cited by 127
l -Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism
Kaiser, R., Höfer, A., Grapengiesser, A., Gasser, T., Kupsch, A. R., Roots, I., & Brockmöller, J. (2003) · Neurology · doi:10.1212/01.wnl.0000068009.32067.a1 · Cited by 126
Development and testing of the Parkinson's disease quality of life scale
Welsh, M. D., McDermott, M., Holloway, R. G., Plumb, S., Pfeiffer, R. F., & Hubble, J. P. (2003) · Movement Disorders · doi:10.1002/mds.10424 · Cited by 117
Fernandez, H. H., & Friedman, J. H. (1999) · Movement Disorders · Cited by 116
Dopamine D2receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD
Oliveri, R. L., Annesi, G., Zappia, M., Civitelli, D., Montesanti, R., Branca, D., Nicoletti, G., Spadafora, P., Pasqua, A. A., Cittadella, R., et al. (1999) · Neurology · doi:10.1212/wnl.53.7.1425 · Cited by 112
Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations
Marras, C., Lang, A. E., Krahn, M. D., TOMLINSON, G. A., Naglie, G., & The Parkinson Study Group (2004) · Movement Disorders · doi:10.1002/mds.10642 · Cited by 112
Sanghera, M. K., Grossman, R. G., Kalhorn, C. G., Hamilton, W. J., Ondo, W. G., & Jankovic, J. J. (2003) · Neurosurgery · doi:10.1227/01.neu.0000064805.91249.f5 · Cited by 111
Self-citationL -Dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations
Pearce, R. K. B., Heikkilä, M., I.-B., L. X. E. N., & Jenner, P. G. (2001) · Psychopharmacology · doi:10.1007/s002130100733 · Cited by 107
Short‐ and long‐duration responses to levodopa during the first year of levodopa therapy
Nutt, J. G., Carter, J. H., Houten, L. V., & Woodward, W. R. (1997) · Annals of Neurology · doi:10.1002/ana.410420311 · Cited by 103
Dystonia in corticobasal degeneration
Vanek, Z. F., & Jankovic, J. J. (2001) · Movement Disorders · doi:10.1002/mds.1038 · Cited by 91
Self-citationAssociation study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD
Wang, J., Liu, Z.-L., & Chen, B. (2001) · Neurology · doi:10.1212/wnl.56.12.1757 · Cited by 86
Progression of Parkinson Disease
Jankovic, J. J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.3.351 · Cited by 84
Self-citationAn ambulatory dyskinesia monitor
Manson, A. J. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.2.196 · Cited by 79
Multiple system atrophy: An update
Wenning, G. K., Geser, F., Stampfer‐Kountchev, M., & Tison, F. (2003) · Movement Disorders · doi:10.1002/mds.10561 · Cited by 71
Pathophysiology of L-dopa-induced dyskinesias.
Bédard, P. J., Blanchet, P. J., Lévesque, D., Soghomonian, J., Grondin, R., Morissette, M., Goulet, M., Calon, F., Falardeau, P., Gomez‐Mancilla, B., et al. (1999) · PubMed · Cited by 63
Respiratory dyskinesia in Parkinson's disease
Jankovic, J. J., & Nour, F. (1986) · Neurology · doi:10.1212/wnl.36.2.303-b · Cited by 43
Self-citationRating scales for dyskinesias in Parkinson's disease.
Cg, G. (1999) · PubMed · Cited by 42
Jankovic, J. J. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200009000-00003 · Cited by 37
Self-citationGriggs, R. C., & McGee, K. (2000) · Neurology · doi:10.1212/wnl.55.1.2 · Cited by 31
Measuring motor complications in clinical trials for early Parkinson's disease
Marras, C., & Lang, A. E. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.2.143 · Cited by 24
Solano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3
Cited by
Duty, S., & Jenner, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01426.x · Cited by 753
Technology in Parkinson’s disease: challenges and opportunities
Espay, A. J., Bonato, P., Nahab, F. B., Maetzler, W., Dean, J. M., Klucken, J., Eskofier, B. M., Merola, A., Horak, F., Lang, A. E., et al. (2016) · Movement Disorders · doi:10.1002/mds.26642 · Cited by 654
Maiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 525
Fabbrini, G., Brotchie, J. M., Grandas, F., Nomoto, M., & Goetz, C. G. (2007) · Movement Disorders · doi:10.1002/mds.21475 · Cited by 464
Advances in the treatment of Parkinson's disease
Singh, N., Pillay, V., & Choonara, Y. E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.009 · Cited by 394
Metadata
- Authors
- Jankovic, J.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2005
- Volume
- 20
- Issue
- S11
- Pages
- S11-S16
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2014583561
- Cited by
- 547
- References
- 55
- FWCI
- 14.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.